ArticleFrontiers in oncology2022

Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer.

Rebekah Rittberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.